Assessment of Magnetic Resonance Imaging Changes and Functional Outcomes Among Adults With Severe Herpes Simplex Encephalitis.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 07 2021
Historique:
entrez: 27 7 2021
pubmed: 28 7 2021
medline: 7 1 2022
Statut: epublish

Résumé

Current guidelines recommend brain magnetic resonance imaging (MRI) for clinical management of patients with severe herpes simplex encephalitis (HSE). However, the prognostic value of brain imaging has not been demonstrated in this setting. To investigate the association between early brain MRI data and functional outcomes of patients with HSE at 90 days after intensive care unit (ICU) admission. This multicenter cohort study was conducted in 34 ICUs in France from 2007 to 2019 and recruited all patients who received a clinical diagnosis of encephalitis and exhibited cerebrospinal fluid positivity for herpes simplex virus DNA in the polymerase chain reaction analysis. Data analysis was performed from January to April 2020. All patients underwent a standard brain MRI during the first 30 days after ICU admission. MRI acquisitions were analyzed by radiologists blinded to patients' outcomes, using a predefined score. Multivariable logistic regression and supervised hierarchical classifiers methods were used to identify factors associated with poor outcome at 90 days, defined by a score of 3 to 6 (indicating moderate-to-severe disability or death) on the Modified Rankin Scale. Overall, 138 patients (median [interquartile range {IQR}] age, 62.6 [54.0-72.0] years; 75 men [54.3%]) with an admission median (IQR) Glasgow Coma Scale score of 9 (6-12) were studied. The median (IQR) delay between ICU admission and MRI was 1 (1-7) days. At 90 days, 95 patients (68.8%) had a poor outcome, including 16 deaths (11.6%). The presence of fluid-attenuated inversion recovery MRI signal abnormalities in more than 3 brain lobes (odds ratio [OR], 25.71; 95% CI, 1.21-554.42), age older than 60 years (OR, 7.62; 95% CI, 2.02-28.91), and the presence of diffusion-weighted MRI signal abnormalities in the left thalamus (OR, 6.90; 95% CI, 1.12-43.00) were independently associated with poor outcome. Machine learning models identified bilateral diffusion abnormalities as an additional factor associated with poor outcome (34 of 39 patients [87.2%] with bilateral abnormalities had poor outcomes) and confirmed the functional burden of left thalamic lesions, particularly in older patients (all 11 patients aged >60 years had left thalamic lesions). These findings suggest that in adult patients with HSE requiring ICU admission, extensive MRI changes in the brain are independently associated with poor functional outcome at 90 days. Thalamic diffusion signal changes were frequently observed and were associated with poor prognosis, mainly in older patients.

Identifiants

pubmed: 34313743
pii: 2782419
doi: 10.1001/jamanetworkopen.2021.14328
pmc: PMC8317014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2114328

Investigateurs

Pierre Jaquet (P)
Etienne de Montmollin (E)
Claire Dupuis (C)
Mikael Alves (M)
Laurent Argaud (L)
Pierre Bailly (P)
François Barbier (F)
Lila Bouadma (L)
Noelle Brulé (N)
Fabrice Brunel (F)
Russell Chabanne (R)
Marie Conrad (M)
Daniel Da Silva (D)
Frederic Dailler (F)
Delphine Daubin (D)
Sophie Demeret (S)
Nicolas Lerolle (N)
Julien Marechal (J)
Bruno Mourvillier (B)
Ahmed El Kalioubi (A)
Benjamine Sarton (B)
Stein Silva (S)
Romain Sonneville (R)
Vincent Susset (V)
Jean Marc Tadié (JM)
Jean-Françoit Timsit (JF)
Michel Wolff (M)
Alexandre Lautrette (A)
Emmanuel Novy (E)
Bertrand Guidet (B)
François Mateos (F)
Clément Brault (C)
Quentin Maestraggi (Q)
Keyvan Razazi (K)
Jean-Pierre Quenot (JP)
Aurélie Joret (A)
Albrice Levrat (A)
Alexandre Massri (A)
Alexandre Robert (A)
Damien Contou (D)
Jean-Paul Mira (JP)
Stephane Gaudry (S)
Guillaume Voiriot (G)
Asael Berger (A)
Vincent Das (V)
Nicolas Engrand (N)
Martin Murgier (M)
Shidasp Siami (S)
Sami Hraiech (S)
Eric Mariotte (E)
Claire Ragot (C)
Annabelle Stoclin (A)
Pierre Trouiller (P)
Mathieu Schmidt (M)
Charline Sazio (C)

Références

Med Mal Infect. 2017 May;47(3):179-194
pubmed: 28412044
Neurology. 2003 Oct 14;61(7):1015-6
pubmed: 14557588
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Clin Radiol. 2016 Oct;71(10):1050-8
pubmed: 27185323
J Neurol. 2017 Jun;264(6):1204-1208
pubmed: 28516331
Med Mal Infect. 2017 May;47(3):221-235
pubmed: 28341533
Intensive Care Med. 2019 Aug;45(8):1103-1111
pubmed: 31292686
J Clin Neurol. 2016 Apr;12(2):224-9
pubmed: 26833985
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Comput Med Imaging Graph. 2001 Sep-Oct;25(5):391-7
pubmed: 11390193
Stroke. 2011 Aug;42(8):2276-9
pubmed: 21680905
Am J Respir Crit Care Med. 2017 Feb 15;195(4):491-499
pubmed: 27552490
Epilepsia. 2009 Feb;50(2):265-75
pubmed: 18717714
Clin Infect Dis. 2007 Oct 1;45(7):875-80
pubmed: 17806053
J Neurol. 2015 Sep;262(9):2101-5
pubmed: 26092520
N Engl J Med. 1977 Aug 11;297(6):289-94
pubmed: 195208
Neurocrit Care. 2005;3(3):251-3
pubmed: 16377839
J Neurol Sci. 2009 Dec 15;287(1-2):221-6
pubmed: 19732907
Crit Care. 2015 Sep 21;19:345
pubmed: 26387515
Crit Care Med. 1981 Aug;9(8):591-7
pubmed: 7261642
Antimicrob Agents Chemother. 2015;59(6):3084-9
pubmed: 25779579
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
J Neuroinflammation. 2019 Jan 29;16(1):19
pubmed: 30696448
Stroke. 2010 May;41(5):1048-50
pubmed: 20224060
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Clin Infect Dis. 2015 May 1;60(9):1377-83
pubmed: 25637586
J Clin Virol. 2014 Jun;60(2):112-8
pubmed: 24768322
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256

Auteurs

Benjamine Sarton (B)

Critical Care Unit, University Hospital of Purpan, Toulouse, France.
Toulouse NeuroImaging Center, Unité Mixte de Recherche 1214, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.

Pierre Jaquet (P)

Department of Intensive Care Medicine and Infectious Diseases, Bichat-Claude Bernard University Hospital, Paris, France.

Djida Belkacemi (D)

Department of Neuroradiology, University Hospital of Purpan, Toulouse, France.

Etienne de Montmollin (E)

Department of Intensive Care Medicine and Infectious Diseases, Bichat-Claude Bernard University Hospital, Paris, France.

Fabrice Bonneville (F)

Toulouse NeuroImaging Center, Unité Mixte de Recherche 1214, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.
Department of Neuroradiology, University Hospital of Purpan, Toulouse, France.

Charline Sazio (C)

Critical Care Unit, University Hospital of Pellegrin, Bordeaux, France.

Aurelien Frérou (A)

Critical Care Unit, University Hospital of Rennes, Rennes, France.

Marie Conrad (M)

Critical Care Unit, Regional and University Hospital of Nancy, Nancy France.

Delphine Daubin (D)

Critical Care Unit, University Hospital of Montpellier, Montpellier, France.

Russell Chabanne (R)

Critical Care Unit, University Hospital Gabriel Montpied, Clermont Ferrand, France.

Laurent Argaud (L)

Critical Care Unit, University Hospital Edouard Herriot, Hospices Civils of Lyon, Lyon, France.

Frédéric Dailler (F)

Neurological Critical Care Unit, Hospital Pierre Wertheimer, Hospices Civils of Lyon, Lyon, France.

Noëlle Brulé (N)

Critical Care Unit, University Hospital of Nantes, Nantes, France.

Nicolas Lerolle (N)

Critical Care Unit, University Hospital of Angers, Angers, France.

Quentin Maestraggi (Q)

Critical Care Unit, University Hospital Hautepierre of Strasbourg, Strasbourg, France.

Julien Marechal (J)

Critical Care Unit, University Hospital La Miletrie, Poitiers, France.

Pierre Bailly (P)

Critical Care Unit, Regional University Hospital La Cavale Blanche, Brest, France.

Keyvan Razazi (K)

Critical Care Unit, University Hospital of Henri Mondor, Créteil, France.

Francois Mateos (F)

Critical Care Unit, Regional Hospital of Saint Brieuc, Saint Brieuc, France.

Bertrand Guidet (B)

Critical Care Unit, University Hospital of Saint Antoine, Paris, France.

Albrice Levrat (A)

Critical Care Unit, University Hospital of Annecy Genevois, Epagny Metz-Tessy, France.

Vincent Susset (V)

Critical Care Unit, Regional Hospital of Chambery, Chambery, France.

Alexandre Lautrette (A)

Critical Care Unit, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Jean-Paul Mira (JP)

Critical Care Unit, University Hospital Cochin, Paris, France.

Ahmed El Kalioubie (A)

Critical Care Unit, University Hospital Salengro, Lille, France.

Alexandre Robert (A)

Critical Care Unit, University Hospital of Nice, Nice, France.

Alexandre Massri (A)

Critical Care Unit, Regional Hospital of Pau, Pau, France.

Jean François Albucher (JF)

Toulouse NeuroImaging Center, Unité Mixte de Recherche 1214, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.
Department of Neurology, University Hospital of Purpan, Toulouse, France.

Jean Marc Olivot (JM)

Toulouse NeuroImaging Center, Unité Mixte de Recherche 1214, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.
Department of Neurology, University Hospital of Purpan, Toulouse, France.

Jean Marie Conil (JM)

Critical Care Unit, University Hospital of Rangueil, Toulouse, France.

Lila Boudma (L)

Department of Intensive Care Medicine and Infectious Diseases, Bichat-Claude Bernard University Hospital, Paris, France.

Jean-François Timsit (JF)

Department of Intensive Care Medicine and Infectious Diseases, Bichat-Claude Bernard University Hospital, Paris, France.

Romain Sonneville (R)

Department of Intensive Care Medicine and Infectious Diseases, Bichat-Claude Bernard University Hospital, Paris, France.
Laboratory for Vascular Translational Science, Sorbonne Paris Cité, Unité Mixte de Recherche 1148, Institut National de la Santé et de la Recherche Médicale, Paris Diderot University, Paris, France.

Stein Silva (S)

Critical Care Unit, University Hospital of Purpan, Toulouse, France.
Toulouse NeuroImaging Center, Unité Mixte de Recherche 1214, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH